Dyne Therapeutics, Inc. · NASDAQ:DYN
Kersten Dirk sold 99,613 Dyne Therapeutics, Inc. shares (Form 4)
Traded Apr 15 to Apr 16, 2026 · Filed Apr 17, 2026
From Apr 15 to Apr 16, 2026, Kersten Dirk (Director) sold 99,613 Dyne Therapeutics, Inc. shares at an average US$20.35 for US$2.03M under a trading plan, leaving 4,544,773 shares. Filed Apr 17, 2026 (Form 4).
- Sold
- 99,613 shares
- Price
- US$20.35 average (US$20.06 to US$21.10)
- Value
- US$2.03M
- Holding after
- 4,544,773 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | Sale | 81,840 | US$20.27 | 4,562,546 | Indirect |
| Apr 16, 2026 | Common Stock | Sale | 11,116 | US$21.10 | 4,551,430 | Indirect |
| Apr 16, 2026 | Common Stock | Sale | 6,657 | US$20.06 | 4,544,773 | Indirect |
Source
Related
- Dyne Therapeutics, Inc.
- Kersten Dirk
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Kersten Dirk · Jul 29, 2026
- Form 4 · Kersten Dirk · Jun 24, 2026
- Form 4 · Kersten Dirk · Jun 22, 2026
- Form 4 · Kersten Dirk · Apr 23, 2026
- Form 4 · Kersten Dirk · Apr 21, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026